QP 14 - Modernizing Definitive Therapy in Cervical Cancer: From Systemic Intensification to Adaptive Radiation

Presentations

• 05:00pm - 05:05pm ET

  Introductions

  Speaker: Naresh Jegadeesh, MD - Cook Radiation Oncology, Chicago
• 05:05pm - 05:10pm ET

  Bone Marrow-Sparing Extended-Field Chemoradiation with Dose-Dense Neoadjuvant Chemotherapy for FIGO 2018 Stage IIIC2 Cervical Cancer: Early Outcomes of a Prospective Phase II Study

  Speaker: Surendra Saini, MD, PhD, DPH, FESTRO - All India Institute of Medical Sciences, New Delhi
• 05:10pm - 05:15pm ET

  Nab-Paclitaxel plus Cisplatin Concurrent with Image Guided Volumetric Modulated Arc Therapy for Locally Advanced Cervical Cancer: Five-Year Follow-Up Results of a Single-Arm, Prospective Study

  Speaker: Shuhua Wei, PhD - Peking University Third Hospital, Beijing
• 05:15pm - 05:20pm ET

  Validation of an Automated Segmentation and Planning Reference Generation System for Gynecologic HDR Brachytherapy

  Speaker: Rebecca Marchant, MD - University of California at San Diego, La Jolla
• 05:20pm - 05:25pm ET

  Nab-Paclitaxel and Cisplatin with Image Guided Volumetric Modulated Arc Therapy for Locally Advanced Cervical Cancer: A Multicenter, Single-Arm Phase II Trial

  Speaker: Shuhua Wei, PhD - Peking University Third Hospital, Beijing
• 05:25pm - 05:30pm ET

  Contrast-Free Virtual Enhancement: Multi-Modal Deep Learning Synthesis of CECT from pCT and MRI

  Speaker: Haonan Xiao, PhD - Shandong First Medical University Affiliated Tumor Hospital, Jinan City
• 05:30pm - 05:35pm ET

  Prospective Two-Year Progression-Free Survival and Toxicity after Daily Online Adaptive Radiotherapy for Cervical Cancer

  Speaker: Guangyu Wang, MD - Peking Union Medical College Hospital, Beijing
• 05:35pm - 05:55pm ET

  Questions & Answers

  Speaker: Jill Remick, MD - Emory University , Atlanta
• 05:55pm - 06:00pm ET

  Closing

  Speaker: Naresh Jegadeesh, MD - Cook Radiation Oncology, Chicago